Patient number | Sex | Age (years) | Smoking | Site | Stage (TNM8) | p16 | HPV DNA | Primary size (mL) | Lymph node masses | |
---|---|---|---|---|---|---|---|---|---|---|
Number | Size (mL) Median (range) | |||||||||
1 | M | 54 | Never | Palatine tonsil | T4aN2b | - | N/A | 31.15 | 2 | 1.90 (1.31–2.50) |
3 | M | 45 | Current | Pyriform fossa | T2N2b | N/A | N/A | 4.35 | 2 | 7.04 (4.27–9.81) |
4 | M | 69 | Ex | Oropharynx | T0N2 | + | + | - | 1 | 10.71 |
5 | M | 66 | Never | Pyriform fossa | T2N1 | + | + | 3.98 | 2 | 6.26 (1.64–10.88) |
6 | M | 46 | Current | Nasopharynx | T1N2 | N/A | N/A | 8.83 | 10 | 2.60 (1.01–20.56) |
7 | M | 66 | Ex | Base of tongue | T4aN2 | + | N/A | 33.70 | 4 | 1.83 (0.37–6.44) |
9 | M | 62 | Never | Base of tongue | T1N1 | + | + | 1.31 | 1 | 11.98 |
10 | M | 55 | Current | Base of tongue | T3N1 | + | + | 5.04 | 2 | 2.90 (0.26–5.55) |
Palatine tonsil | T3N0 | + | + | 17.69 | − | − | ||||
11 | M | 72 | Ex | Pyriform fossa | T4aN1 | N/A | N/A | 33.11 | 1 | 0.46 |
13 | F | 59 | Current | Vallecula | T1N2c | - | - | 0.54 | 1 | 9.94 |
14 | M | 56 | Current | Palatine tonsil | T4aN2b | + | - | 21.60 | 3 | 1.10 (0.48–8.40) |
15 | M | 38 | Current | Palatine tonsil | T1N1 | + | + | 2.35 | 7 | 2.62 (0.54–7.19) |
16 | M | 65 | Never | Palatine tonsil | T2N1 | + | N/A | 3.75 | 2 | 6.00 (0.93–11.07) |
19 | F | 76 | Never | Palatine tonsil | T2N1 | + | + | 4.55 | 1 | 8.35 |
20 | M | 57 | Current | Larynx | T3N2b | N/A | N/A | 7.20 | 2 | 1.52 (1.17–1.87) |
 | Median (range) | 5.04 (0.26–33.70) | 2 (1–10) | 2.62 (0.26–20.56) | ||||||
 | Total number of lesions | 15 | 41 | - |